PL3307065T3 - Komórki chimeryczne związane z dystrofią mięśniową i sposób leczenia dystrofii mięśniowych - Google Patents
Komórki chimeryczne związane z dystrofią mięśniową i sposób leczenia dystrofii mięśniowychInfo
- Publication number
- PL3307065T3 PL3307065T3 PL16808341.8T PL16808341T PL3307065T3 PL 3307065 T3 PL3307065 T3 PL 3307065T3 PL 16808341 T PL16808341 T PL 16808341T PL 3307065 T3 PL3307065 T3 PL 3307065T3
- Authority
- PL
- Poland
- Prior art keywords
- muscular
- treating
- chimeric cells
- dystrophies
- muscular dystrophy
- Prior art date
Links
- 201000006938 muscular dystrophy Diseases 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562174122P | 2015-06-11 | 2015-06-11 | |
| PCT/US2016/036821 WO2016201182A1 (en) | 2015-06-11 | 2016-06-10 | Muscular dystrophy chimeric cells and method for treating muscular dystrophies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3307065T3 true PL3307065T3 (pl) | 2024-02-19 |
Family
ID=57504278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16808341.8T PL3307065T3 (pl) | 2015-06-11 | 2016-06-10 | Komórki chimeryczne związane z dystrofią mięśniową i sposób leczenia dystrofii mięśniowych |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11147840B2 (pl) |
| EP (1) | EP3307065B1 (pl) |
| JP (1) | JP6890553B2 (pl) |
| CN (1) | CN107920503A (pl) |
| AU (1) | AU2016274797B2 (pl) |
| CA (1) | CA2988137C (pl) |
| ES (1) | ES2962633T3 (pl) |
| PL (1) | PL3307065T3 (pl) |
| WO (1) | WO2016201182A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016274797B2 (en) * | 2015-06-11 | 2018-09-27 | The Board Of Trustees Of The University Of Illinios | Muscular Dystrophy Chimeric Cells and method for treating muscular dystrophies |
| CN111406106A (zh) * | 2017-11-28 | 2020-07-10 | 伊利诺伊大学理事会 | 多嵌合细胞以及移植疗法与免疫缺陷和遗传病症的治疗 |
| WO2020186197A1 (en) * | 2019-03-14 | 2020-09-17 | Dystrogen Therapeutics Corporation | Myoblast chimeric cells (mccs) |
| CN119286772B (zh) * | 2024-12-12 | 2025-02-25 | 中国海洋大学三亚海洋研究院 | 一种海水鱼类成肌细胞体外增殖方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659663A (en) * | 1984-10-01 | 1987-04-21 | Board Of Regents, University Of Texas System | Methods for isolating cell fusion products |
| US5538722A (en) | 1989-06-13 | 1996-07-23 | Stanford University | Isolation, growth, differentiation and genetic engineering of human muscle cells |
| GB9419048D0 (en) | 1994-09-20 | 1994-11-09 | Watt Diana J | Treatment of muscular disorders |
| CN1127343C (zh) * | 1994-12-13 | 2003-11-12 | 彼得·K·罗 | 治疗哺乳动物疾病的成肌细胞组合物 |
| US20020164313A1 (en) * | 1995-03-16 | 2002-11-07 | Tremblay Jacques P. | Compositions comprising preconditioned myoblasts having enhanced fusion properties |
| WO2000024869A2 (en) * | 1998-10-23 | 2000-05-04 | Yale University | Methods for modulating cell fusion |
| US6740751B2 (en) * | 2000-07-18 | 2004-05-25 | Board Of Regents, The University Of Texas System | Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| BR0211400A (pt) | 2001-07-23 | 2004-11-09 | Viacell Inc | Tratamento de distrofia muscular com células de sangue do cordão |
| US20040001857A1 (en) * | 2002-06-28 | 2004-01-01 | Cheung Ling Yuk | Dietary supplements for treating hypertension |
| ATE507290T1 (de) * | 2004-07-27 | 2011-05-15 | Kowa Co | Zellfusionspromotor und dessen nutzung |
| CA2538208A1 (en) * | 2005-05-04 | 2006-11-04 | Universite Laval | Modulation of myostatin and use thereof in cell transplantation-based treatment of muscle disease |
| US20070253931A1 (en) * | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
| US20080286249A1 (en) | 2006-01-12 | 2008-11-20 | Varney Timothy R | Use of mesenchymal stem cells for treating genetic diseases and disorders |
| CN104651299B (zh) * | 2007-04-06 | 2022-07-26 | 国际干细胞公司 | 源于人单性生殖胚泡的患者特异性干细胞系 |
| US8703180B1 (en) | 2007-10-23 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| WO2010031190A1 (en) * | 2008-09-22 | 2010-03-25 | UNIVERSITé LAVAL | Culture medium for myoblasts, precursors thereof and derivatives thereof |
| US10272137B2 (en) | 2013-06-27 | 2019-04-30 | The Board Of Regents Of The University Of Texas System | Compositions and methods relating to myomaker-induced muscle cell fusion |
| AU2016274797B2 (en) * | 2015-06-11 | 2018-09-27 | The Board Of Trustees Of The University Of Illinios | Muscular Dystrophy Chimeric Cells and method for treating muscular dystrophies |
-
2016
- 2016-06-10 AU AU2016274797A patent/AU2016274797B2/en active Active
- 2016-06-10 CA CA2988137A patent/CA2988137C/en active Active
- 2016-06-10 CN CN201680033733.2A patent/CN107920503A/zh active Pending
- 2016-06-10 EP EP16808341.8A patent/EP3307065B1/en active Active
- 2016-06-10 US US15/580,783 patent/US11147840B2/en active Active
- 2016-06-10 PL PL16808341.8T patent/PL3307065T3/pl unknown
- 2016-06-10 JP JP2017564642A patent/JP6890553B2/ja active Active
- 2016-06-10 WO PCT/US2016/036821 patent/WO2016201182A1/en not_active Ceased
- 2016-06-10 ES ES16808341T patent/ES2962633T3/es active Active
-
2021
- 2021-10-12 US US17/498,901 patent/US20220025335A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016201182A1 (en) | 2016-12-15 |
| CN107920503A (zh) | 2018-04-17 |
| CA2988137C (en) | 2021-01-26 |
| EP3307065A1 (en) | 2018-04-18 |
| EP3307065B1 (en) | 2023-08-02 |
| EP3307065A4 (en) | 2018-04-25 |
| AU2016274797A1 (en) | 2018-01-18 |
| ES2962633T3 (es) | 2024-03-20 |
| WO2016201182A8 (en) | 2017-01-05 |
| CA2988137A1 (en) | 2016-12-15 |
| JP6890553B2 (ja) | 2021-06-18 |
| AU2016274797B2 (en) | 2018-09-27 |
| JP2018516974A (ja) | 2018-06-28 |
| US20220025335A1 (en) | 2022-01-27 |
| US20180221416A1 (en) | 2018-08-09 |
| US11147840B2 (en) | 2021-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258211A (en) | Methods for treating muscular dystrophy | |
| GB201509463D0 (en) | Improved apparatus and method | |
| GB2538806B (en) | Method and apparatus | |
| GB201515082D0 (en) | Apparatus & method | |
| EP3244656A4 (en) | Cell selection method and apparatus | |
| SG11201801385XA (en) | Storage apparatus and storage method | |
| GB201405130D0 (en) | Electrochemical method and apparatus | |
| GB201516031D0 (en) | Apparatus & method | |
| GB201510322D0 (en) | Apparatus and method | |
| HUE043397T2 (hu) | Eljárás és berendezés erõforrások összehangolására | |
| PL3307065T3 (pl) | Komórki chimeryczne związane z dystrofią mięśniową i sposób leczenia dystrofii mięśniowych | |
| GB201515111D0 (en) | Method and apparatus | |
| GB201513472D0 (en) | Apparatus and method | |
| GB201517314D0 (en) | Apparatus and method | |
| GB201503194D0 (en) | Method and apparatus | |
| SG11201803077UA (en) | Cell treatment apparatus | |
| GB201516706D0 (en) | Method and apparatus for interference reduction | |
| EP3304961A4 (en) | Method and apparatus for cell configuration | |
| GB201507917D0 (en) | Apparatus and method | |
| SG11201803079QA (en) | Cell treatment apparatus | |
| PT3256700T (pt) | Método para armazenamento de energia | |
| GB201603641D0 (en) | Apparatus and method | |
| GB201523095D0 (en) | Apparatus and method | |
| GB201520333D0 (en) | Handling apparatus & method | |
| GB201519859D0 (en) | Method and apparatus |